{name}
{subtitle}
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~79 mi. (Kazan, Russia, +176 more cities)
facility
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 2646)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
city
~79 mi. (Kazan, Russia, +158 more cities)
facility
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1911)
drug
olaparib, +4 more drugs
drug type
chemotherapy, +3 more types
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~79 mi. (Kazan, Russia, +260 more cities)
facility
Republican Clinical Oncological Dispensary of the Ministry of Healthcare; Chemotherapy department
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)
city
~79 mi. (Kazan, Russia, +45 more cities)
facility
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1509)
drug
cisplatin, +5 more drugs
drug type
chemotherapy, +2 more types
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
city
~79 mi. (Kazan, Russia, +122 more cities)
facility
Republican Clinical Oncology Dispensary-Chemotherapy #1 ( Site 1814)
drug
etoposide, +5 more drugs
drug type
chemotherapy, +3 more types
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~79 mi. (Kazan, Russia, +150 more cities)
facility
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1000)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
city
~79 mi. (Kazan, Russia, +179 more cities)
facility
Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic
drug
atezolizumab, +1 more drug
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)
city
~79 mi. (Kazan, Russia, +127 more cities)
facility
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 2609)
drug
lenvatinib, +1 more drug
drug type
immunotherapy, +1 more type
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
city
~79 mi. (Kazan, Russia, +126 more cities)
facility
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 0412)
drug
FOLFOX regimen, +3 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)
city
~79 mi. (Kazan, Russia, +67 more cities)
facility
Republican Clinical Oncology Dispensary-Chemotherapy #1 ( Site 1425)
drug
carboplatin, +5 more drugs
drug type
chemotherapy, +1 more type
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~79 mi. (Kazan, Russia, +145 more cities)
facility
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 2001)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types